Assessment of the reliability and validity of a novel point-of-care fibrinogen (F-Point) device against an industry standard at fibrinogen levels > 2  g/L in non-haemorrhage scenarios

The detection and correction of coagulopathy is an important aspect of the management of obstetric haemorrhage.1 Fibrinogen concentration has been shown to be an independent predictor of progression to severe postpartum haemorrhage (PPH), with a fibrinogen level of4  g/L having a negative predictive value of 79% for the progression to severe PPH.2
Source: International Journal of Obstetric Anesthesia - Category: Anesthesiology Authors: Tags: Short report Source Type: research